Biblio
XPO1 is a new target of homoharringtonine (HHT): Making NPMc AML cells much more sensitive to HHT treatment. Biochem Biophys Res Commun. 2023;675:155-161.
. Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene. Exp Hematol Oncol. 2023;12(1):19.